San Diego, CA -- (SBWire) -- 06/20/2022 --An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Akebia Therapeutics, Inc..
Investors who are current long term investors in Akebia Therapeutics, Inc. (NASDAQ: AKBA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: AKBA stocks follows a lawsuit filed against Akebia Therapeutics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: AKBA stocks, concerns whether certain Akebia Therapeutics, Inc. directors are liable in connection with the allegations made in that lawsuit.
The plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose that vadadustat was not as safe in treating NDD-CKD patients with anemia as Defendants had represented, that as a result, Defendants overstated the PRO2TECT Program's clinical prospects, that accordingly, Defendants also overstated vadadustat's overall commercial and regulatory prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Akebia Therapeutics, Inc. (NASDAQ: AKBA) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Long Term Investor Alert: Investigation of Potential Wrongdoing
An investigation on behalf of current long term investors in Akebia Therapeutics, Inc. (NASDAQ:AKBA) shares over possible breaches of fiduciary duty by certain officers and directors was announced.